Sex differences in cardiovascular outcome during progression of aortic valve stenosis

Heart

Volumn 101, Issue 3, 2015, Pages 209-214

  Cramariuc, Dana ^a   Rogge, Barbara Patricia ^a,b   Lønnebakken, Mai Tone ^b   Boman, Kurt ^c   Bahlmann, Edda ^d   Gohlke Bärwolf, Christa ^e   Chambers, John B ^f   Pedersen, Terje R ^g   Gerdts, Eva ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UMEÅ UNIVERSITY   (Sweden)

^d DEPARTMENT OF CARDIOLOGY   (Germany)

^e UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^f GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^g ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANALYSIS OF VARIANCE; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; AORTIC VALVE STENOSIS; CLINICAL TRIAL; EPIDEMIOLOGY; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; MULTICENTER STUDY; NORWAY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; SEX RATIO; SURVIVAL RATE; SYSTOLE; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; NORWAY; PROGNOSIS; SEX DISTRIBUTION; SEX FACTORS; SIMVASTATIN; SURVIVAL RATE; SYSTOLE; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84920873327     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2014-306078     Document Type: Article

References (28)

1. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-43.
2. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11.
3. Otto CM. Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol 2006;47:2141-51.
4. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009;22:1-23.
5. Aurigemma GP, Silver KH, McLaughlin M, et al. Impact of chamber geometry and gender on left ventricular systolic function in patients >60 years of age with aortic stenosis. Am J Cardiol 1994;74:794-8.
6. Carroll JD, Carroll EP, Feldman T, et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 1992;86:1099-107.
7. Douglas PS, Otto CM, Mickel MC, et al. Gender differences in left ventricle geometry and function in patients undergoing balloon dilatation of the aortic valve for isolated aortic stenosis. NHLBI Balloon Valvuloplasty Registry. Br Heart J 1995;73:548-54.
8. Cramariuc D, Gerdts E, Davidsen ES, et al. Myocardial deformation in aortic valve stenosis: relation to left ventricular geometry. Heart 2010;96:106-12.
9. Aggarwal SR, Clavel MA, Messika-Zeitoun D, et al. Sex differences in aortic valve calcification measured by multidetector computed tomography in aortic stenosis. Circ Cardiovasc Imaging 2013;6:40-7.
10. Cramariuc D, Rieck AE, Staal EM, et al . Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy). Am J Cardiol 2008;101:510-15.
11. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
12. Rieck AE, Cramariuc D, Staal EM, et al . Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy). J Hypertens 2010;28:377-83.
13. Shames S, Gillam LD. Sex differences in aortic valve calcification. Circ Cardiovasc Imaging 2013;6:8-10.
14. Rossebo AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008;359:1343-56.
15. Bahlmann E, Gerdts E, Cramariuc D, et al. Prognostic value of energy loss index in asymptomatic aortic stenosis. Circulation 2013;127:1149-56.
16. de Simone G, Izzo R, Chinali M, et al. Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? Hypertension 2010;56:99-104.
17. Bella JN, Palmieri V, Roman MJ, et al. Gender differences in left ventricular systolic function in American Indians (from the Strong Heart Study). Am J Cardiol 2006;98:834-7.
18. Gerdts E, Stangeland L, Engedal H, et al. Postoperative Doppler echocardiographic evaluation in different sizes of Medtronic-Hall, Biocor and Carpentier-Edwards S.A.V. prosthetic aortic valves. Scand J Thorac Cardiovasc Surg 1994;28:25-9.
19. Petrov G, Regitz-Zagrosek V, Lehmkuhl E, et al. Regression of myocardial hypertrophy after aortic valve replacement: faster in women? Circulation 2010;122 (11 Suppl):S23-8.
20. Villari B, Campbell SE, Schneider J, et al. Sex-dependent differences in left ventricular function and structure in chronic pressure overload. Eur Heart J 1995;16:1410-19.
21. Novaro GM, Katz R, Aviles RJ, et al. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. J Am Coll Cardiol 2007;50:1992-8.
22. Rosenhek R, Klaar U, Schemper M, et al. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J 2004;25:199-205.
23. Mannsverk J, Wilsgaard T, Njolstad I, et al. Age and gender differences in incidence and case fatality trends for myocardial infarction: a 30-year follow-up. The Tromso Study. Eur J Prev Cardiol 2012;19:927-34.
24. Pibarot P, Dumesnil JG. Assessment of aortic stenosis severity: check the valve but don't forget the arteries! Heart 2007;93:780-2.
25. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012;125: e2-220.
26. Williams M, Kodali SK, Hahn RT, et al. Sex-related differences in outcomes following transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights From The PARTNER Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 2014;63:1522-8.
27. Nishimura RA, Otto CM, Bonow RO, et al . 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2438-88.
28. Rieck AE, Cramariuc D, Boman K, et al. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events. Hypertension 2012;60:90-7.